logo
Twitter
Discord
Email
logo
Altria Group, Inc.

Altria Group, Inc.

NYSE•MO
CEO: Mr. William F. Gifford Jr.
Sector: Consumer Defensive
Industry: Tobacco
Listing Date: 1985-07-01
Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company offers cigarettes primarily under the Marlboro brand; large cigars and pipe tobacco under the Black & Mild brand; moist smokeless tobacco and snus products under the Copenhagen, Skoal, Red Seal, and Husky brands; oral nicotine pouches under the on! brand; and e-vapor products under the NJOY ACE brand. It sells its products to distributors, as well as large retail organizations, such as chain stores. The company was founded in 1822 and is headquartered in Richmond, Virginia.
Contact Information
6601 West Broad Street, Richmond, VA, 23230, United States
804-274-2200
www.altria.com
Market Cap
$103.67B
P/E (TTM)
11.7
22.6
Dividend Yield
6.7%
52W High
$68.60
52W Low
$50.08
52W Range
63%
Rank13Top 2.2%
6.8
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Strong • 6.8 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2016-2025

Financial Dashboard

Q3 2025 Data

Revenue

$5.25B-1.74%
4-Quarter Trend

EPS

$1.41+5.22%
4-Quarter Trend

FCF

$3.04B+17.83%
4-Quarter Trend

2025 Q3 Earnings Highlights

Key Highlights

Adjusted Earnings Growth Strong Adjusted net earnings rose 3.6% to $6,966M for nine months; Adjusted diluted EPS increased 5.9% to $4.12.
Smokeable OCI Margin Expansion Smokeable products reported OCI margin at 63.8%, up 2.3 points, driven by higher pricing offsetting volume declines.
Oral Tobacco OCI Jumps Oral tobacco OCI surged 39.6% to $1.39B for nine months, benefiting from prior year impairment comparison.
Dividend Rate Increased Quarterly dividend raised 3.9% to $1.06 per share; current annualized rate stands at $4.24 per share.

Risk Factors

E-Vapor Goodwill Impairment Recorded $873M non-cash goodwill impairment for e-vapor unit following ITC exclusion order on NJOY ACE sales.
Ongoing Tobacco Litigation Exposure Tobacco and health litigation resulted in $44M pre-tax charges for nine months; outcomes remain uncertain.
Regulatory Uncertainty Persists FDA proposing maximum nicotine standard for cigarettes; illicit flavored disposables continue to challenge e-vapor growth.
Stockholders' Equity Deficit Widens Total stockholders' equity deficit increased to $2.596B due to share repurchases and accumulated losses.

Outlook

Share Repurchase Program Expanded Board authorized $1.0B expansion to $2.0B repurchase program, now expiring December 31, 2026.
Focus on Smoke-Free Transition Vision remains Moving Beyond Smoking™, competing vigorously for smoke-free consumers and exploring new growth.
Long-Term Debt Issuance Issued $2.0B in senior unsecured notes during 2025 to fund general corporate purposes and debt repayment.
Monitoring Macroeconomic Pressures Closely monitoring discretionary income pressures, tariffs, and illicit product proliferation impacting consumer purchasing behavior.

Peer Comparison

Revenue (TTM)

Unilever PLCUL
$130.25B
+2.5%
Anheuser-Busch InBev SA/NVBUD
$88.66B
+49.3%
British American Tobacco p.l.c.BTI
$66.17B
-5.2%

Gross Margin (Latest Quarter)

Unilever PLCUL
100.0%
+0.0pp
British American Tobacco p.l.c.BTI
83.6%
+1.1pp
Altria Group, Inc.MO
72.6%
+1.3pp

Key Metrics

Symbol
Market Cap
P/E (TTM)
ROE (TTM)
Debt to Assets
UL$140.76B35.720.1%42.1%
BUD$133.56B16.010.1%0.0%
BTI$126.43B31.26.3%32.0%

Long-Term Trends

Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
0.9%
Moderate Growth
4Q Net Income CAGR
-7.9%
Declining Profitability
Cash Flow Stability
100%
Strong Cash Flow

Research & Insights

Next earnings:Jan 29, 2026
|
EPS:$1.30
|
Revenue:$5.02B
Reports
All Years

  • Form 10-Q - Q3 2025

    Period End: Sep 30, 2025|Filed: Oct 30, 2025|
    Revenue: $5.25B-1.7%
    |
    EPS: $1.41+5.2%
    Meet

  • Form 10-Q - Q2 2025

    Period End: Jun 30, 2025|Filed: Jul 30, 2025|
    Revenue: $5.29B+0.2%
    |
    EPS: $1.41-36.2%
    Meet

  • Form 10-K/A - FY 2024

    Period End: Dec 31, 2024|Filed: Jun 4, 2025|
    Revenue: $20.44B-0.3%
    |
    EPS: $6.54+41.9%
    Beat

  • Form 10-Q - Q1 2025

    Period End: Mar 31, 2025|Filed: Apr 29, 2025|
    Revenue: $4.52B-4.2%
    |
    EPS: $0.63-47.9%
    Miss

  • Form 10-K - FY 2024

    Period End: Dec 31, 2024|Filed: Feb 26, 2025|Refer to amended data

  • Form 10-Q - Q3 2024

    Period End: Sep 30, 2024|Filed: Oct 31, 2024|
    Revenue: $5.34B+1.3%
    |
    EPS: $1.34+9.8%
    Meet

  • Form 10-Q - Q2 2024

    Period End: Jun 30, 2024|Filed: Jul 31, 2024|
    Revenue: $5.28B-3.0%
    |
    EPS: $2.21+85.7%
    Beat

  • Form 10-K/A - FY 2023

    Period End: Dec 31, 2023|Filed: Jun 5, 2024|
    Revenue: $20.50B-0.9%
    |
    EPS: $4.61+44.5%
    Beat